期刊文献+

激素替代治疗对绝经后妇女血清脂蛋白(a)的影响 被引量:1

Effect of hormone replacement therapy on serum lipoprotein (a) in postmenopausal women
下载PDF
导出
摘要 目的 探讨戊酸雌二醇和倍美力对心血管疾病独立危险因子脂蛋白(a)[Lp(a)]的影响。方法 60例绝经后病例,按1:1随机分成两组,行连续序贯方案治疗,其中倍美力组30例口服结合雌激素0.625mg/d加醋酸甲孕酮4mg/d;戊酸雌二醇组30例口服戊酸雌二醇1mg/d加醋酸甲孕酮4mg/d。两组均连续治疗16周,于用药前、用药9周、16周取血测定血Lp(a),同时测血雌二醇水平。结果 两组用药后9周和16周Lp(a)均显著下降(P<0.01);两组间用药各时相Lp(a)水平差异无显著性(P>0.05)。两组用药前后E_2水平均显著升高(P<0.01),达正常月经周期早卵泡期水平。结论 激素替代治疗可使心血管疾病独立危险因子Lp(a)降低。 Objective To study the effects of estradial valerate on serum lipoprotein (a) within 16 weeks treatment. Methods Sixty patients of postmenopausal women were divided into 2 groups randomly. Thirty patients were given conjugated estrogen 0.625 mg daily, while 4mg medroxyprogesterone acetate was added sequentially. Thirty patients were given estradial valerate 1mg daily. Serum level of lipoprotein (a) was measured before and after 9 weeks and 16 weeks of treatment. Serum level of estradiol was measured simultaneously. Results Serum level of lipoprotein (a) was decreased after 9 and 16 weeks treatment significantly in both groups. There was no significant difference between two groups, however serum level of estradiol was increased significantly in both groups.Conclusion Postmenopausal hormone replacement therapy may reduce lipoprotein (a), an independent risk factor of coronary artery disease.
出处 《中国妇产科临床杂志》 2001年第4期225-227,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 激素替代治疗 脂蛋白(a) 绝经 Hormone replacement therapy Lipoprotein (a) Menopause
  • 相关文献

参考文献8

  • 1[1]AndersenLF, GramJ, SkoubySO, etal. Effects of hormone replacement therapy on hemostatic cardiovascular risk factors. Am J Obstet Gynecol,1999, 180:283-289
  • 2[2]Cheung AP. Acute effects of estradiol and progesterone on insulin, lipids and lipoproteins in postmenopausal women: a pilot study. Maturitas,2000, 35:45-50
  • 3[3]PaassiltaM, KarjalainenA, Kervinen K, et al. Insulin- like growth factor binding protein - 1 (IGFBP - 1 ) and IGF - I during oral and transdermal estrogen replacement therapy: relation to lipoprotein (a) levels.Atherosclerosis, 2000, 149: 157-162
  • 4[4]VehkavaaraS, HakalaAPT, VirkamakiA, etal. Differential Effects of Oral and Transdermal Estrogen Replacement Therapy on Endothelial Function in Postmenopausal Women. Circulation, 2000, 102: 26872693.
  • 5[5]Lobo RA, Zacur HZ, Caubel P, et al. A novel intermittent regimen of norgestimate to preserve the beneficial effects of17beta- estradiol oo lipid and lipoprotein profiles. AmJ Obstet Gynecol, 2000, 182:41-49
  • 6[6]Mijatovic V, Mooren MJ, Kenemans P, et al. Raloxffene lowers serum lipoprotein (A) in healthy postmenopausal women: a randomized, double -blind, placebo- controlled comparison with conjugated equine estrogens. Menopause, 1999, 6: 134-137.
  • 7[7]Sacks FM, McPherson R, Walsh BM. Effect of post - menopausal estrogen replacement on plasma Lp (a) lipo - protein concentrations. Arch Intern Med, 1994; 154: 1106- 1112
  • 8[8]Wen Y, Doyle MC, NorrisLA, etal. Combined oestrogen-progestogen replacement therapy does not inhibit low - density lipoprotein oxidation in postmenooparsal women. Br J Clin Pharmacol, 1999, 47: 315-21.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部